ClinicalTrials.gg
WithdrawnNCT02473874Updated Nov 1, 2022

Comparison Imaging System Between Spatially Modulated Quantitative Spectroscopy and Skin Spect Dermoscopy

An observational study in Melanocytic Nevus, sponsored by University of California, Irvine. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-01.

Sponsored by University of California, Irvine · Observational

Why this study was withdrawn
Not NIH defined clinical trial study.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to obtain skin spectroscopic data from two imaging systems.

Comparison groups:

  • Skin Spect dermoscope
  • Spatially modulated quantitative spectrometer
Read the detailed description

The researcher can compare the spectroscopic data from the two systems as well as the relative concentrations of melanin, oxy- and deoxy- hemoglobin calculated from the measurements.

Skin Spect can measure larger area of skin, whereas Spatially modulated quantitative spectrometer is a point-based measurement.Therefore, larger nevi will require multiple Spatially modulated quantitative spectrometer measurements for comparison with corresponding sub-regions of the larger Skin Spect measurements. Only sub-regions of the image data from Skin Spect that match the locations Spatially modulated quantitative spectrometer acquired data will be used in this correlation study.

This researcher ensure that the spectral data collected by the two instruments are collected from the same spatial locations, should lesion heterogeneity be present.

02

Conditions studied

  • Melanocytic Nevus

Browse trials for

03

In context

Nevus, Pigmented

19 studies on the registry are indexed under Nevus, Pigmented; 6 are open to participants now.

Browse Nevus, Pigmented studies →

Lead sponsor

University of California, Irvine is the lead sponsor of 476 studies on the registry; 98 are open to participants now.

Of its 41 completed or terminated interventional studies of FDA-regulated products, 30 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects will be recruited from an outpatient population of subjects at Beckman Laser Medical Clinic, University of California, Irvine.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Skin lesion a mole located on flat surface of the body

Exclusion criteria

Exclusion Criteria:

  • Mole located on complex surface
  • Pregnant women
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Skin Spect dermoscope

    Skin mole

    Device: Skin Spect dermoscope

  • Spatially modulated quantitative

    Skin mole

    Device: Spatially modulated quantitative

Interventions

  • DeviceSkin Spect dermoscope

    Skin imaging

  • DeviceSpatially modulated quantitative

    Skin imaging

06

What researchers measure

Primary outcomes

  1. Changes in human skin structure

    Comparison Imaging Changes in human skin structure Between Spatially Modulated Quantitative Spectroscopy and Skin Spect Dermoscopy

    Time frame: up to 12 weeks

07

Study locations

1 site
  • Beckman Laser Institute
    Irvine, California 92612, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02473874
Collaborators
Beckman Laser Institute University of California Irvine
Responsible party
Beckman Laser Institute and Medical Center (Kristen Kelly, M.D., Professor of Dermatology and Surgery, University of California, Irvine) — Principal investigator
First posted
Jun 17, 2015
Start date
Jun 2015
Primary completion
Jan 2020
Completion
Jan 2020
Last update
Nov 1, 2022

Study contacts

Kristen Kelly, MD
principal investigator · Beckman Laser Institute, UCI

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion